Sensitisation for Specific Lysis in Target-Effektor-System with Derivatives of Chelidonium majus Alkaloids - Ukrain.
J. NOWICKY*, W. HIESMAYR*, W. NOWICKY*
*Ukrainian Anti-Cancer Institute, Vienna, Austria
Previous in vitro and in vivo studies and clinical results with immune-deficiency syndrome patients treated with Ukrain, a semisynthetic drug from alkaloids of Chelidonium majus L. and thiophosphoric acid (1) showed immune-stimulating and immune-modulating properties in various test systems. The experiments described here were designed to examine the possibilities of influence of the biocatalyst Ukrain in vitro system environments on certain cell-systems, such as effector-target.